BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 27939129)

  • 1. Guillain Barré Syndrome is induced in Non-Obese Diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics.
    St Charles JL; Bell JA; Gadsden BJ; Malik A; Cooke H; Van de Grift LK; Kim HY; Smith EJ; Mansfield LS
    J Autoimmun; 2017 Feb; 77():11-38. PubMed ID: 27939129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?
    Kuwabara S; Ogawara K; Misawa S; Koga M; Mori M; Hiraga A; Kanesaka T; Hattori T; Yuki N
    Neurology; 2004 Aug; 63(3):529-33. PubMed ID: 15304587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice.
    Brooks PT; Brakel KA; Bell JA; Bejcek CE; Gilpin T; Brudvig JM; Mansfield LS
    Microbiome; 2017 Aug; 5(1):92. PubMed ID: 28789710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th1/Th17-mediated Immunity and Protection from Peripheral Neuropathy in Wildtype and IL10
    Brudvig JM; Cluett MM; Gensterblum-Miller EU; Chen J; Bell JA; Mansfield LS
    Comp Med; 2022 Apr; 72(2):63-77. PubMed ID: 35272743
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
    Prendergast MM; Moran AP
    J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
    Yuki N
    Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
    Yuki N
    J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
    Komagamine T; Yuki N
    CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):391-400. PubMed ID: 16918391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of Guillain-Barré syndrome.
    Hughes RA; Hadden RD; Gregson NA; Smith KJ
    J Neuroimmunol; 1999 Dec; 100(1-2):74-97. PubMed ID: 10695718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity and cytokines in Guillain-Barré syndrome revisited: review of pathomechanisms with an eye on therapeutic options.
    Ebrahim Soltani Z; Rahmani F; Rezaei N
    Eur Cytokine Netw; 2019 Mar; 30(1):1-14. PubMed ID: 31074417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
    Yuki N; Odaka M
    Curr Opin Neurol; 2005 Oct; 18(5):557-61. PubMed ID: 16155440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
    Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N
    J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome subtypes related to Campylobacter infection.
    Drenthen J; Yuki N; Meulstee J; Maathuis EM; van Doorn PA; Visser GH; Blok JH; Jacobs BC
    J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):300-5. PubMed ID: 21270063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
    Ho TW; Mishu B; Li CY; Gao CY; Cornblath DR; Griffin JW; Asbury AK; Blaser MJ; McKhann GM
    Brain; 1995 Jun; 118 ( Pt 3)():597-605. PubMed ID: 7600081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes.
    Yuki N
    Lancet Infect Dis; 2001 Aug; 1(1):29-37. PubMed ID: 11871407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome?
    Yuki N; Koga M; Hirata K
    Acta Neurol Scand; 2000 Aug; 102(2):132-4. PubMed ID: 10949532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Malik A; Brudvig JM; Gadsden BJ; Ethridge AD; Mansfield LS
    Gut Microbes; 2022; 14(1):2064706. PubMed ID: 35442154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.